微信直播

AUA 2016|Dr. Gary E. Lemack:如何有效监测神经源性泌尿障碍?

Published at: 2015年第1卷第S1期

高明珍
关键词:

编者按:2016年5月6日-10日,美国泌尿协会年会(American Urological Association Annual Meeting; 简称AUA)在美国圣迭戈(San Diego)顺利举行。 本届年会由美国泌尿协会主办,来自美国肯塔基大学医学院的 William F. Gee 教授为大会主席。大会聚集了世界众多泌尿领域顶级大咖,分享泌尿科最新进展和洞悉前沿研究趋势。

 

在此次会议中,美国德克萨斯大学西南医学中心的 Gary E. Lemack 教授作为神经源性泌尿病例讨论会场的主持人,与来自世界各地的17位专家共同探讨了混合性尿失禁、性功能障碍等。会后笔者有幸邀请到 Lemack 教授做一个简单的访谈,与大家分享其对神经源性泌尿疾病的看法。


图:Dr. Gary E. Lemack 与 AME 编辑合影

采访问题

  1. How to evaluate and surveille neurourologic dysfunction?

  2. What’s the best surveillance for neurourologic dysfunction?

  3. Should patients with transverse myelitis(TM) and lower urinary tract symptoms (LUTS) have thorough baseline urological evaluations including urodynamics and be offered ongoing surveillance?

  4. Is suprapubic catheterization (SPC) an effective bladder management in patients with neurogenic bladder (NGB).

  5. Any advances about neurourologic dysfunction?

  6. Do you have anything else in this field would like to share with our readers?

访谈视频


 

专家介绍

Gary Lemack, M.D., is a Professor in the Department of Urology at UT Southwestern Medical Center and has a secondary appointment in the Department of Neurology.

He is Director of Urodynamics in the Department of Urology at Parkland Memorial Hospital and he has been the Residency Program Director in the Department of Urology since 2004. His clinical specialties include incontinence, pelvic organ prolapse, and voiding dysfunction in the setting of neurologic disease. He is also active in research. His clinical research has focused on the use of urodynamic studies in patients with lower urinary tract dysfunction/incontinence, and on establishing best urological practices in the care of patients with multiple sclerosis and other neurological conditions.

 

采访编辑丨高明珍,科学编辑,AME 出版社

视频编辑丨麦雪芳,视频编辑,AME 出版社

 

相关阅读:

doi:10.3978/kysj.2014.1.1920

comments powered by Disqus

附件